Targeting Peroxisome Proliferator-Activated Receptor Gamma for Generation of Antidiabetic Drug

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|9|4|275-285

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.9, Iss.4, 2013-07, pp. : 275-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptor- in macrophage lipid homeostasis

By Lee C.-H.   Evans R.M.  

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 8, 2002-10 ,pp. : 331-335

Elsevier

Access to resources Recommend Favorite

Pioglitazone, a Specific Ligand of the Peroxisome Proliferator-Activated Receptor Gamma Reduces Gastric Mucosal Injury Induced by Ischaemia/Reperfusion in Rat

By Konturek P. C.   Brzozowski T.   Kania J.   Kukharsky V.   Bazela K.   Kwiecien S.   Harsch I.   Konturek S. J.   Hahn E. G.  

Scandinavian Journal of Gastroenterology, Vol. 38, Iss. 5, 2003-01 ,pp. : 468-476

Informa Healthcare

Access to resources Recommend Favorite

Association Analysis of Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Late Onset Alzheimer’s Disease in the Finnish Population

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 449-453

Karger

Access to resources Recommend Favorite

A Ligand for Peroxisome Proliferator-Activated Receptor γ Inhibits Human Cholangiocarcinoma Cell Growth: Potential Molecular Targeting Strategy for Cholangioma

By Kobuke T.   Tazuma S.   Hyogo H.   Chayama K.  

Digestive Diseases and Sciences, Vol. 51, Iss. 9, 2006-09 ,pp. : 1650-1657

Springer Publishing Company

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

By  

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite